Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    86,321.25
    -1,753.23 (-1.99%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Metlife assumes about 200,000 COVID-19 deaths in U.S. in third quarter

A MetLife Inc building is shown in Irvine, California

NEW YORK (Reuters) - Metlife Inc <MET.N> said on Thursday it assumes U.S. deaths from COVID-19 will rise to about 200,000 by the end of September, but the disease is having minimal overall impact on underwriting.

"We continue to anticipate modest underwriting impacts from COVID-19 on a combined basis, assuming death rises in the U.S. to approximately 200,000 through the third quarter," Chief Financial Officer John McCallion said on a conference call with investors. MetLife released earnings on Wednesday.

(Reporting by Alwyn Scott and Suzanne Barlyn; Editing by Chris Reese)